These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26865716)

  • 1. MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
    Ruiz AJ; Hadac EM; Nace RA; Russell SJ
    J Virol; 2016 Apr; 90(8):4078-4092. PubMed ID: 26865716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model.
    Penza V; Maroun JW; Nace RA; Schulze AJ; Russell SJ
    Mol Ther Oncolytics; 2023 Mar; 28():15-30. PubMed ID: 36619293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insert Stability and In Vivo Testing of MicroRNA-Detargeted Oncolytic Picornaviruses.
    Schulze AJ
    Methods Mol Biol; 2020; 2058():77-94. PubMed ID: 31486032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-detargeting proves more effective than
    Suryawanshi YR; Nace RA; Russell SJ; Schulze AJ
    Mol Ther Oncolytics; 2021 Dec; 23():1-13. PubMed ID: 34589580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.
    Lee CY; Rennie PS; Jia WW
    Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus.
    Ramachandran M; Yu D; Dyczynski M; Baskaran S; Zhang L; Lulla A; Lulla V; Saul S; Nelander S; Dimberg A; Merits A; Leja-Jarblad J; Essand M
    Clin Cancer Res; 2017 Mar; 23(6):1519-1530. PubMed ID: 27637889
    [No Abstract]   [Full Text] [Related]  

  • 7. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
    He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
    J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.
    Baertsch MA; Leber MF; Bossow S; Singh M; Engeland CE; Albert J; Grossardt C; Jäger D; von Kalle C; Ungerechts G
    Cancer Gene Ther; 2014 Sep; 21(9):373-80. PubMed ID: 25145311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and oncolytic viruses.
    Ruiz AJ; Russell SJ
    Curr Opin Virol; 2015 Aug; 13():40-8. PubMed ID: 25863717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of genetically engineered mengoviruses in mice.
    Osorio JE; Grossberg SE; Palmenberg AC
    Viral Immunol; 2000; 13(1):27-35. PubMed ID: 10733166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
    Leber MF; Bossow S; Leonard VH; Zaoui K; Grossardt C; Frenzke M; Miest T; Sawall S; Cattaneo R; von Kalle C; Ungerechts G
    Mol Ther; 2011 Jun; 19(6):1097-106. PubMed ID: 21468006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-based Regulation of Picornavirus Tropism.
    Ruiz AJ; Russell SJ
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy.
    Shayestehpour M; Moghim S; Salimi V; Jalilvand S; Yavarian J; Romani B; Mokhtari-Azad T
    Virus Res; 2017 Aug; 240():207-214. PubMed ID: 28867494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells.
    Cawood R; Chen HH; Carroll F; Bazan-Peregrino M; van Rooijen N; Seymour LW
    PLoS Pathog; 2009 May; 5(5):e1000440. PubMed ID: 19461878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting.
    Ylösmäki E; Martikainen M; Hinkkanen A; Saksela K
    J Virol; 2013 Jan; 87(1):335-44. PubMed ID: 23077310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture.
    Martin LR; Neal ZC; McBride MS; Palmenberg AC
    J Virol; 2000 Apr; 74(7):3074-81. PubMed ID: 10708422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome.
    Yen LC; Lin YL; Sung HH; Liao JT; Tsao CH; Su CM; Lin CK; Liao CL
    Vaccine; 2013 Dec; 31(49):5915-22. PubMed ID: 22008823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenic and pathogenic potential of short poly(C) tract Mengo viruses.
    Osorio JE; Martin LR; Palmenberg AC
    Virology; 1996 Sep; 223(2):344-50. PubMed ID: 8806569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication.
    Edge RE; Falls TJ; Brown CW; Lichty BD; Atkins H; Bell JC
    Mol Ther; 2008 Aug; 16(8):1437-43. PubMed ID: 18560417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.